Frequently Asked Questions
The Opioid Receptor Agonist Market will grow at a CAGR of 4.50% during the forecast period of 2022 to 2029.
The rise in the incidence of chronic pain in adults, growing cases of orthopedic diseases, and increase in the geriatric population flourishing the growth of the Opioid Receptor Agonist Market.
The major players operating in the opioid receptor agonist market are Teva Pharmaceutical Industries Ltd, Johnson & Johnson Services, Inc, Pfizer Inc, Fresenius Kabi AG, Mylan N.V., Allergan, US WorldMeds, LLC, Piramal Critical Care, DAIICHI SANKYO COMPANY, LIMITED, Purdue Pharma L.P., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc, Sun Pharmaceutical Industries Ltd, Tris Pharma, Inc and Indivior PLC among others.
The initiation of generics version of branded drugs are poised to restrict the Opioid Receptor Agonist Market growth.
